Europe Pediatric Perfusion Market Growth, Size, Trends, Share, Revenue and Future Outlook
Europe Pediatric Perfusion Market Size- By Product, By Applications, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Jun-2024 | Report ID: HLCA2459 | Pages: 1 - 154 | Formats*: |
| Category : Healthcare | |||
Europe Pediatric Perfusion Market Introduction and Overview
According to SPER Market Research, the Europe Pediatric Perfusion Market is estimated to reach USD XX billion by 2033 with a CAGR of 5.81%.
The report includes an in-depth analysis of the Europe Pediatric Perfusion Market, including market size and trends, product mix, applications, and supplier analysis. During open heart surgery, pediatric perfusion attends to the respiratory and circulatory requirements of the young patient. During surgery, a child's blood circulation and oxygenation are supported with pediatric perfusion devices. During a surgical treatment, these devices make sure that the child's important organs receive oxygen and nourishment. Pediatric perfusion pumps are essential for treating a number of congenital cardiac conditions. Surgery may be necessary to correct these anomalies, which can range in severity from minor to severe. There are several different kinds of pediatric perfusion devices on the market, including cardiac monitors, blood pumps, pediatric cannulas, heart-lung machines, and oxygenators.
- March 2023; Established in the UK, LivaNova is a medical device firm that received approval from the US food and Drug Administration to introduce Essenz Heart Lung Machine in the US market. The Essenz Heart Lung Machine and the LivaNova patient monitor work together to create the perfusion system that is utilized during cardiopulmonary bypass procedures.
Market Opportunities and Challenges
Opportunities- The pediatric perfusion industry offers a lot of opportunities, especially for equipment invention and development that is smaller in size. These devices offer more accurate control and fewer problems, making them more suitable for the physiological requirements of newborns and babies. This constitutes a noteworthy progression in the field of juvenile cardiac treatment, presenting a compelling prospect for industry participants. In emerging nations, where access to pediatric cardiac care is improving and the healthcare infrastructure is growing, there is also room for expansion. The increasing need for healthcare services in these areas may encourage the growth of the market.
Challenges- The market for pediatric perfusion faces a number of difficulties, including the sometimes drawn-out and complicated process of regulatory compliance and approval. Financial constraints arise due to the high cost of new medical equipment, particularly for smaller healthcare facilities. Staffing problems are made worse by the shortage of pediatric perfusionists with specific training. The picture is further complicated by strict standards for clinical trials and testing, ethical considerations, and parental approval. Equal access to cutting-edge treatments is further hampered by regional differences in healthcare infrastructure and financial limitations. Complexity is increased by lack of consistency in treatment protocols, technological obstacles, and integration challenges. To provide the best possible care, healthcare providers' awareness and education also require a great deal of progress.
Market Competitive Landscape
A lot of companies are focusing on organic growth strategies, such as product launches, approvals, and other techniques including patents and events. The market witnessed the following inorganic growth strategies: partnerships, acquisitions, and collaborations. The major players in the market are BL Lifesciences, Cardinal Health, Inc., EUROSETS S.R.L. (GVM Care Research), GE HealthCare Technologies, Inc., Getinge AB, Koninklijke Philips N.V., LivaNova PLC, Medtronic PLC, Nonin Medical, Inc., and Terumo Corporation.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Product, By Application, By End-Use |
| Regions covered | Eastern Europe, Southern Europe, Western Europe, and Northern Europe |
| Companies Covered | BL Lifesciences, Cardinal Health, Inc., EUROSETS S.R.L. (GVM Care Research), GE HealthCare Technologies, Inc., Getinge AB, Koninklijke Philips N.V., LivaNova PLC, Medtronic PLC, Nonin Medical, Inc., and Terumo Corporation. |
COVID-19 Impact on Europe Pediatric Perfusion Market
Due to the cancellation or postponement of elective cardiac procedures, the COVID-19 pandemic temporarily hurt the business. Additionally, as the number of COVID cases increased, attention was diverted from paediatric patients in need to COVID cases at that particular moment. However, it was anticipated that the industry would pick up steam when things get better and the healthcare systems bounce back. As a result of hospitals allocating resources to address the rise in COVID-19 cases, pediatric perfusion systems were less accessible and used.
Key Target Audience:
- Pediatric Cardiology Centers
- Pediatric Intensive Care Units (PICUs)
- Children’s Hospitals
- Academic and Research Institutions
- Healthcare Providers and Professionals
- Parent and Patient Advocacy Groups
Our in-depth analysis of the Europe Pediatric Perfusion Market includes the following segments:
| By Product: |
|
| By Application: |
|
| By End-Use: |
|
Key Topics Covered in the Report:
- Europe Pediatric Perfusion Market Size (FY’2024-FY’2033)
- Overview of Europe Pediatric Perfusion Market
- Segmentation of Europe Pediatric Perfusion Market By Product (Oxygenators, Cannulas and Catheters)
- Segmentation of Europe Pediatric Perfusion Market By Application (Cardiac Surgeries, Organ Transplantation)
- Segmentation of Europe Pediatric Perfusion Market By End-Use (Hospitals, Cardiac Centers)
- Statistical Snap of Europe Pediatric Perfusion Market
- Expansion Analysis of Europe Pediatric Perfusion Market
- Problems and Obstacles in Europe Pediatric Perfusion Market
- Competitive Landscape in the Europe Pediatric Perfusion Market
- Impact of COVID-19 and Demonetization on Europe Pediatric Perfusion Market
- Details on Current Investment in Europe Pediatric Perfusion Market
- Competitive Analysis of Europe Pediatric Perfusion Market
- Prominent Players in the Europe Pediatric Perfusion Market
- SWOT Analysis of Europe Pediatric Perfusion Market
- Europe Pediatric Perfusion Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges4.2. COVID-19 Impacts of the Europe Pediatric Perfusion Market.
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Europe Pediatric Perfusion Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Pediatric Perfusion Market
7. Europe Pediatric Perfusion Market, By Product (USD Million) 2020-2033
7.1. Europe Pediatric Perfusion Market Size, Share and Forecast, By Product, 2020-20267.2. Europe Pediatric Perfusion Market Size, Share and Forecast, By Product, 2027-20337.3. Oxygenators7.4. Cannulas and Catheters7.5. Blood Pumps7.6. Arterial Filters
8. Europe Pediatric Perfusion Market, By Application (USD Million) 2020-2033
8.1. Europe Pediatric Perfusion Market Size, Share and Forecast, By Application, 2020-20268.2. Europe Pediatric Perfusion Market Size, Share and Forecast, By Application, 2027-20338.3. Cardiac Surgeries8.4. Organ Transplantation
9. Europe Pediatric Perfusion Market, By End-Use (USD Million) 2020-2033
9.1. Europe Pediatric Perfusion Market Size, Share and Forecast, By End-Use, 2020-20269.2. Europe Pediatric Perfusion Market Size, Share and Forecast, By End-Use, 2027-20339.3. Hospitals9.4. Cardiac Centers
10. Europe Pediatric Perfusion Market Forecast, 2020-2033 (USD Million)
10.1. Europe Pediatric Perfusion Market Size and Market Share
11. Europe Pediatric Perfusion Market, By Region, 2020-2033 (USD Million)
11.1. Europe Pediatric Perfusion Market Size and Market Share By Region (2020-2026)11.2. Europe Pediatric Perfusion Market Size and Market Share By Region (2027-2033)11.3. Eastern Europe11.4. Southern Europe11.5. Western Europe11.6. Northern Europe
12. Company Profile
12.1. BL LIFESCIENCES12.1.1. Company details12.1.2. Financial outlook12.1.3. Product summary12.1.4. Recent developments12.2. CARDINAL HEALTH, INC12.2.1. Company details12.2.2. Financial outlook12.2.3. Product summary12.2.4. Recent developments12.3. EUROSETS S.R.L (GVM CARE RESEARCH)12.3.1. Company details12.3.2. Financial outlook12.3.3. Product summary12.3.4. Recent developments12.4. GE HEALTHCARE TECHNOLOGIES, INC12.4.1. Company details12.4.2. Financial outlook12.4.3. Product summary12.5. GETINGE AB12.4.4. Recent developments12.5.1. Company details12.5.2. Financial outlook12.5.3. Product summary12.5.4. Recent developments12.6. KONINKLIJKE PHILIPS N.V.12.6.1. Company details12.6.2. Financial outlook12.6.3. Product summary12.6.4. Recent developments12.7. LIVANOVA PLC12.7.1. Company details12.7.2. Financial outlook12.7.3. Product summary12.7.4. Recent developments12.8. MEDTRONIC PLC12.8.1. Company details12.8.2. Financial outlook12.8.3. Product summary12.8.4. Recent developments12.9. NONIN MEDICAL, INC12.9.1. Company details12.9.2. Financial outlook12.9.3. Product summary12.9.4. Recent developments12.10. TERUMO CORPORATION12.10.1. Company details12.10.2. Financial outlook12.10.3. Product summary12.10.4. Recent developments12.11. OTHERS
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Europe Pediatric Perfusion Market is projected to reach USD XX billion by 2033, growing at a CAGR of 5.81% during the forecast period.
Europe Pediatric Perfusion Market grew in market size from 2023. The Market is expected to reach USD XX billion by 2033, at a CAGR of 5.81% during the forecast period.
Europe Pediatric Perfusion Market CAGR of 5.81% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Europe Pediatric Perfusion Market size is USD XX billion from 2024 to 2033.
Europe Pediatric Perfusion Market segment is Covered By Product, By Application, By End-Use.
The Europe region is anticipated to have the highest market share in the Europe Pediatric Perfusion Market .
The key players in the market include Companies Covered BL Lifesciences, Cardinal Health, Inc., EUROSETS S.R.L. (GVM Care Research), GE HealthCare Technologies, Inc., Getinge AB, Koninklijke Philips N.V., LivaNova PLC, Medtronic PLC, Nonin Medical, Inc., and Terumo Corporation.
The increasing need for healthcare services in these areas may encourage the growth of the market.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
